Literature DB >> 18175804

Identification of a novel pool of extracellular pro-myostatin in skeletal muscle.

Sarah B Anderson1, Alfred L Goldberg, Malcolm Whitman.   

Abstract

Myostatin, a transforming growth factor-beta superfamily ligand, negatively regulates skeletal muscle growth. Generation of the mature signaling peptide requires cleavage of pro-myostatin by a proprotein convertase, which is thought to occur constitutively in the Golgi apparatus. In serum, mature myostatin is found in an inactive, non-covalent complex with its prodomain. We find that in skeletal muscle, unlike serum, myostatin is present extracellularly as uncleaved pro-myostatin. In cultured cells, co-expression of pro-myostatin and latent transforming growth factor-beta-binding protein-3 (LTBP-3) sequesters pro-myostatin in the extracellular matrix, and secreted pro-myostatin can be cleaved extracellularly by the proprotein convertase furin. Co-expression of LTBP-3 with myostatin reduces phosphorylation of Smad2, and ectopic expression of LTBP-3 in mature mouse skeletal muscle increases fiber area, consistent with reduction of myostatin activity. We propose that extracellular pro-myostatin constitutes the major pool of latent myostatin in muscle. Post-secretion activation of this pool by furin family proprotein convertases may therefore represent a major control point for activation of myostatin in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175804     DOI: 10.1074/jbc.M706678200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

2.  Skeletal muscle gene expression after myostatin knockout in mature mice.

Authors:  Stephen Welle; Andrew Cardillo; Michelle Zanche; Rabi Tawil
Journal:  Physiol Genomics       Date:  2009-06-09       Impact factor: 3.107

Review 3.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

4.  Latent TGF-β structure and activation.

Authors:  Minlong Shi; Jianghai Zhu; Rui Wang; Xing Chen; Lizhi Mi; Thomas Walz; Timothy A Springer
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

5.  Novel strategies for improving physical function.

Authors:  Shalender Bhasin; Ravi Jasuja; Powen Tu; Thomas W Storer; Wen Guo
Journal:  Horm Res Paediatr       Date:  2011-07-21       Impact factor: 2.852

6.  Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia.

Authors:  Chunliu Pan; Neha Jaiswal Agrawal; Yanni Zulia; Shalini Singh; Kai Sha; James L Mohler; Kevin H Eng; Joe V Chakkalakal; John J Krolewski; Kent L Nastiuk
Journal:  JCI Insight       Date:  2020-03-26

Review 7.  LTBPs in biology and medicine: LTBP diseases.

Authors:  Daniel B Rifkin; William J Rifkin; Lior Zilberberg
Journal:  Matrix Biol       Date:  2017-12-05       Impact factor: 11.583

8.  High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.

Authors:  Michiko Yamada; Ryuichi Tatsumi; Keitaro Yamanouchi; Tohru Hosoyama; Sei-ichi Shiratsuchi; Akiko Sato; Wataru Mizunoya; Yoshihide Ikeuchi; Mitsuhiro Furuse; Ronald E Allen
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

9.  Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

Authors:  Tingqing Guo; William Jou; Tatyana Chanturiya; Jennifer Portas; Oksana Gavrilova; Alexandra C McPherron
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

10.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.